These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9204866)

  • 1. Pertussis toxin: transition state analysis for ADP-ribosylation of G-protein peptide alphai3C20.
    Scheuring J; Schramm VL
    Biochemistry; 1997 Jul; 36(27):8215-23. PubMed ID: 9204866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin.
    Scheuring J; Schramm VL
    Biochemistry; 1997 Apr; 36(15):4526-34. PubMed ID: 9109661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition-state structure for the ADP-ribosylation of recombinant Gialpha1 subunits by pertussis toxin.
    Scheuring J; Berti PJ; Schramm VL
    Biochemistry; 1998 Mar; 37(9):2748-58. PubMed ID: 9485425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit.
    Locht C; Antoine R
    Biochimie; 1995; 77(5):333-40. PubMed ID: 8527486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to detect toxin-catalyzed ADP-ribosylation in intact cells: its use to study the action of Pasteurella multocida toxin.
    Staddon JM; Bouzyk MM; Rozengurt E
    J Cell Biol; 1991 Nov; 115(4):949-58. PubMed ID: 1835459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-ribosylation of alpha i3C20 by the S1 subunit and deletion peptides of S1 of pertussis toxin.
    Finck-Barbançon V; Barbieri JT
    Biochemistry; 1995 Jan; 34(3):1070-5. PubMed ID: 7827022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states.
    Zhou GC; Parikh SL; Tyler PC; Evans GB; Furneaux RH; Zubkova OV; Benjes PA; Schramm VL
    J Am Chem Soc; 2004 May; 126(18):5690-8. PubMed ID: 15125661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of [32P]ADP-ribosylation by pertussis toxin to determine Gi alpha content in membranes from various human tissues. Improved radioimmunological quantification using the 125I-labelled C-terminal decapeptide of retinal transducin.
    Böhm M; Larisch K; Erdmann E; Camps M; Jakobs K; Gierschik P
    Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):223-9. PubMed ID: 1906710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus.
    Avigan J; Murtagh JJ; Stevens LA; Angus CW; Moss J; Vaughan M
    Biochemistry; 1992 Aug; 31(33):7736-40. PubMed ID: 1510959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide inhibitors of ADP-ribosylation by pertussis toxin are substrates with affinities comparable to those of the trimeric GTP-binding proteins.
    Graf R; Codina J; Birnbaumer L
    Mol Pharmacol; 1992 Nov; 42(5):760-4. PubMed ID: 1435750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous inhibitor of the ADP-ribosylation of (a) G-protein(s) as catalyzed by pertussis toxin is present in rat liver.
    Hara-Yokoyama M; Furuyama S
    FEBS Lett; 1988 Jul; 234(1):27-30. PubMed ID: 3134255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras transformation greatly increases the toxin-dependent ADP-ribosylation of GTP binding proteins in thyroid cells. Involvement of an inhibitor of the ADP-ribosylation reaction.
    Di Girolamo M; D'Arcangelo D; Cacciamani T; Gierschik P; Corda D
    J Biol Chem; 1992 Aug; 267(24):17397-403. PubMed ID: 1512271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis toxin-catalyzed ADP-ribosylation of GTP-binding proteins with digoxigenin-conjugated NAD. Identification of the proteins in plasma membranes and nuclei.
    Takei Y; Takahashi K; Kanaho Y; Katada T
    FEBS Lett; 1994 Feb; 338(3):264-6. PubMed ID: 8307191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin.
    Xu Y; Barbançon-Finck V; Barbieri JT
    J Biol Chem; 1994 Apr; 269(13):9993-9. PubMed ID: 8144593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site.
    West RE; Moss J; Vaughan M; Liu T; Liu TY
    J Biol Chem; 1985 Nov; 260(27):14428-30. PubMed ID: 3863818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis toxin induces structural changes in G alpha proteins independently of ADP-ribosylation.
    Ribeiro-Neto FA; Rodbell M
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2577-81. PubMed ID: 2523074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of ADP-ribosylation for the pertussis toxin-induced alteration in electrophoretic mobility of G-proteins.
    Roerig SC; Loh HH; Law PY
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1227-32. PubMed ID: 1835388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent labeling of signal-transducing G-proteins. Pertussis toxin-catalyzed etheno-ADP ribosylation of transducin.
    Hingorani VN; Ho YK
    J Biol Chem; 1988 Dec; 263(36):19804-8. PubMed ID: 3143731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.